FindTrial
Sign In

To evaluate prevalence of Hepatitis A virus in Indian children

Seroprevalence study of Hepatitis A virus antibody in Indian children

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2011/09/002005
Enrollment
1068
Registered
2011-09-14
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Children with no history of Hepatitis A vaccination

Interventions

None listed

Sponsors

Wockhardt Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Indian children of either sex within the age group of 15 months to 10 years (inclusive). 2. Children seeking medical treatment for health problem or minor non infective illness or attending follow/up visit or healthy child examination and requiring blood draw for any indication 3. Patient?s parents / guardians / subjects having the willingness and ability to understand and provide written consent on behalf of subject / assent by the subject to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Children with documented history or suspected with jaundice 2. Children with documented history of Hepatitis A vaccination. 3. Children with current symptoms of viral hepatitis / chronic hepatitis.

Design outcomes

Primary

MeasureTime frame
To evaluate the seroprevalence of antiHAV antibodies in Indian children aged 15 months to 10 years and its association with various sociodemographic variablesTimepoint: One visit—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Ganesh Kadhe
gkadhe@wockhardtin.com022267086403

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026